Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

25.20 24.89 39.81 45.58
P/S ratio
1.94 1.99 1.99 1.86
P/FCF ratio
15.85 16.56 12.63 12.98
P/Operating CF
22.86 66.32 65.76 53.59
P/B ratio
1.67 1.72 1.83 1.70
EV/Sales
2.71 2.71 2.61 2.42
EV/EBITDA
11.74 11.56 11.92 11.39
EV/FCF
22.16 22.60 16.54 16.93
Current Ratio
1.11 1.05 0.94 0.87
Net Debt/EBITDA
9.58 13.63 22.33 10.32
Debt/Equity
0.69 0.67 0.61 0.55
Earnings Yield
3.97% 4.02% 2.51% 2.19%
Free Cash Flow Yield
6.31% 6.04% 7.92% 7.70%
Free Cash Flow per Share
5.13 1.92 1.95 2.30
Book value per Share
88.27 88.53 85.99 88.85
Free Cash Flow
1,475.00 549.00 546.00 633.00
EV/EBIT
22.95 22.23 24.25 23.50
Other line items

Show all line items

Columns are period end dates